.12
6.19%
-0.0076
(Pre-market:
.12
+0
+0.00%)
Apr-12-22 05:30AM | Check These 3 Hot Penny Stocks Out For Your List This WeekPennyStocks |
Apr-06-22 05:53AM | Penny Stocks to Watch as the Fed Tightens its Monetary Policy PennyStocks |
Mar-14-22 06:09AM | Good Trending Penny Stocks to Buy Now? Check These 3 Out PennyStocks |
Mar-09-22 09:49AM | 4 Top Penny Stocks To Buy For Under $1 This WeekPennyStocks |
Feb-02-22 02:54AM | Popular Reddit Penny Stocks to Watch In February 2022PennyStocks |
Jan-31-22 01:56AM | 5 Top Penny Stocks To Buy Under $1 On Webull According To RedditPennyStocks |
Nov-19-21 08:15AM | Exicure, Inc. (XCUR) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research |
Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for immuno-oncology, genetic disorders, and other indications. Its three clinical programs include AST-008, which is in a Phase I clinical trial, an SNA consisting of toll-like receptor 9 that is designed for immuno-oncology applications; XCUR17, which is in a Phase I clinical trial, an SNA that targets the messenger RNA (mRNA) encoding interleukin 17 receptor alpha, a protein that helps in the initiation and maintenance of psoriasis; and AST-005, which is in a Phase I clinical trial, an SNA that targets TNF for the treatment of mild to moderate psoriasis. Exicure, Inc. has collaboration agreements with Allergan plc; DERMELIX, LLC; and Purdue Pharma L.P. The company was founded in 2011 and is headquartered in Skokie, Illinois.
List of SPAC Stocks
List of EV Stocks and Related Stocks
Top 100 popular stocks on Robinhood
List of Marijuana Stocks
Cap:
|
Volume (24h):